|
Volumn 15, Issue 5, 1999, Pages 861-871
|
Differences in induction of p53, p21WAF1 and apoptosis in relation to cell cycle phase of MCF-7 cells treated with camptothecin.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BAX PROTEIN, HUMAN;
CAMPTOTHECIN;
CDKN1A PROTEIN, HUMAN;
CYCLIN DEPENDENT KINASE INHIBITOR 1A;
CYCLINE;
CYCLOHEXIMIDE;
DNA TOPOISOMERASE;
ENZYME INHIBITOR;
ONCOPROTEIN;
PROTEIN BAX;
PROTEIN BCL 2;
PROTEIN P53;
APOPTOSIS;
ARTICLE;
BIOSYNTHESIS;
BREAST TUMOR;
CELL CULTURE;
CELL CYCLE;
DNA REPLICATION;
DRUG ANTAGONISM;
DRUG EFFECT;
FEMALE;
HUMAN;
IMMUNOHISTOCHEMISTRY;
KINETICS;
APOPTOSIS;
BCL-2-ASSOCIATED X PROTEIN;
BREAST NEOPLASMS;
CAMPTOTHECIN;
CELL CYCLE;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
CYCLINS;
CYCLOHEXIMIDE;
DNA REPLICATION;
DNA TOPOISOMERASES, TYPE I;
ENZYME INHIBITORS;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
KINETICS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
TUMOR CELLS, CULTURED;
TUMOR SUPPRESSOR PROTEIN P53;
MLCS;
MLOWN;
|
EID: 0033226985
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.15.5.861 Document Type: Article |
Times cited : (44)
|
References (0)
|